Approval · Notice of Compliance 24820 · 2020
INCRELEX: Notice of Compliance 24820
Issued December 17, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24820
- Date
- December 17, 2020
- Company
- Ipsen Biopharmaceuticals Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INCRELEX | 02509733 | Marketed |
Medicinal ingredients
- MECASERMIN 10 MG per ML